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Abstract
Berberine the main antibacterial substance in the rhi-
zome of Coptis chinensis Franch, is used as an antimi-
crobial agent for a long time. This study was carried
out to investigate the potential of berberine alone or
in combinationwith enro£oxacin against six common
¢sh pathogens for use in ¢sh disease management in
aquaculture. The minimum inhibitory concentrations
(MICs) of berberine hydrochloride against Aeromonas
hydrophila, Pseudomonas £uorescens, Vibrio vulni¢cus,
Edwardsiella ictaluri, Escherichia coli and Streptococcus
agalactiae were determined and to be 4500, 4500,
4500, 300, 400 and 100 mgmL1 respectively. The
minimal bactericidal concentrations (MBCs) of berber-
ine hydrochloride to E. coli, E. ictaluri and S. agalactiae
were 300^500 mgmL1. In combination with enro-
£oxacin, the MICs and MBCs of berberine hydrochlor-
ide signi¢cantly decreased against E. coli and E. ictaluri
but not against Streptococcus dysgalactiae.These results
demonstrated that the berberine hydrochloride en-
hanced the bactericidal e¡ect of enro£oxacin and vice
versa. The synergistic bactericidal e¡ect of berberine
hydrochloride and enro£oxacin suggest its potential
use in ¢sh disease management in aquaculture. This
is the ¢rst study on the inhibitory e¡ect of berberine
hydrochloride against ¢sh pathogenic bacteria.
Keywords: berberine hydrochloride, enro£oxacin,
¢sh pathogenic bacteria, synergistic e¡ect
Introduction
Appropriate antimicrobial therapy represents one of
the most e¡ective management responses to emer-
gencies associated with infectious disease epidemics.
The use of chemicals and antibiotics, however, has
the potential to increase the frequencies of bacterial
resistance and this would have a negative impact on
the subsequent use of these agents to control infec-
tious disease in aquaculture. In addition, there is also
a possibility that the enrichment of resistant bacteria
or genes encoding resistance could have an adverse
impact on the use of antimicrobial agents to control
diseases in humans and other land-based animals.
Therefore, the use of chemicals and antibiotics is fa-
cing greater restriction in the aquaculture industry.
China is a major aquaculture country, accounting
for nearly 70% of theworld’s total aquaculture output;
however, there are so many kinds of ¢sh diseases
caused by pathogenic bacteria, such as Aeromonas hy-
drophila, Pseudomonas £uorescens, Streptococcus spp.,
Edwardsiella ictaluri andVibrio spp., which caused se-
vere economical loss in aquaculture throughout Chi-
na. Looking for alternative treatments to ¢sh diseases
caused by various bacteria, suchas the use of Chinese
herbmedicines or plant extracts, to replace, or reduce
the reliance on antibiotics is thought as a solution to
this problem.
Traditional Chinese medicines in combination
with chemical medicines has been given special at-
tentions in the area of human medicine, veterinary
medicine and ¢sh disease control in China because
of the low price and low toxicity of traditional
Chinese drugs (Lu, Ding & Chen 2008).
Berberine [18,5,6-dihydro-9,10-dimethoxybenzo(g)-
1,3-benzodioxolo (5,6-a) quinolizinium], a naturally
occurring isoquinoline alkaloid, has been found in
roots and bark of various Berberis species [e.g., Ber-
beris vulgaris (barberry), Berberis aquifolium (Oregon
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grape), Berberis aristata (tree turmeric) and Tinospora
cordifolia]. The extracts of these species have been
used as an antidiarrhoeal drug and an antibacterial
agent, and now it has been synthesized. Berberine
has awide range of pharmacological e¡ects. It can in-
hibit fungi, such as Candida albicans, Candida tropicalis
andCandida glabrata (Nakamoto, Sadamori & Hamada
1990). Berberine sulphate has been demonstrated to
reduce the infectivity of bacteria, fungi and protozoa
in both animals and humans (Subbaiah & Amin1967;
Amin, Subbaiah & Abbasi 1969). Berberine hydro-
chloride, the most commonly used form of berberine,
in combination with £uconazole can result in potent
synergistic action against £uconazole-resistant C. al-
bicans in vitro (Quan, Cao, Xu, Zhao, Gao, Qin & Jiang
2006). Furthermore, berberine is the best starting
structure to look for new cationic alkaloids with dou-
ble isoquinolinoid skeleton, acting as antifungal
agents (Enriz & Freile 2006).
The aims of this study are to explore the potential
use of berberine alone and together with chemical
antimicrobials and antibiotics, in order to substitute
or cut down the wide use of these chemical antimi-
crobials and antibiotics in aquaculture, which had
caused a series of environmental and food safety pro-
blems. For this purpose, Escherichia coli, E. ictaluri,
A. hydrophila, P. £uorescens,Vibrio harveyiand Strepto-
coccus dysgalactiaewere selected to test because they
are themost common ¢sh bacterial pathogens in Chi-
nese aquaculture practices. This work will be the
starting point to study the underlying mechanism of
the activity of berberine and berberine combined
with antibiotics to the pathogens.
Materials and methods
Bacterial strains and growth conditions
Five archived strains of ¢sh pathogenic bacteria and
one strain of E. coli listed in Table 1were used in the
present study. All strains except E. coli were isolated
from diseased ¢sh and originally con¢rmed to be
pathogenic to ¢sh. All bacterial strains were stored
at 80 1C as usual. Before testing, the archived bac-
teria were removed from the ultra freezer, allowed to
thaw to room temperature, cultured in broth and in-
cubated at 25 1C for 24 h to reach the log growth
phase of the isolates.
In this study, brain heart infusion media (BHI, Ox-
oid, Basingstoke, UK) for E. ictaluri and S. dysgalac-
tiae, trypticase soy broth (TSB) and tryptonic soy
agar (Difco Laboratories, Detroit, MI, USA) for the
other bacteria were used to culture bacteria in this
study. For the culture ofV. harveyi, a ¢nal concentra-
tion of 2% of sodium chloride was supplemented to
the media (Donovan & van Netten1995).
Antimicrobial agents
The antimicrobials tested in this study included arti-
¢cially synthesized berberine hydrochloride powder
(purity, 97.1%) and enro£oxacin powder (purity,
99.1%). Both chemicals were obtained fromWuhan
Jiuzhou Shengnong Pharmaceutical (Wuhan, Hubei
province, China). They were dissolved in appropriate
solvents (PBS, pH7.4) to make stock solutions, and
then further diluted in BHI or TSB. After ¢ltration
through sterile a 0.22 mmmembrane, stock solutions
were frozen at 20 1C until use. The concentrations
of stock solutions of berberine hydrochloride and
enro£oxacin were 1000 mgmL1 (pH 6.4) and
1000 mgmL1 (pH 7.0) respectively.
Minimal inhibitory concentration (MIC)
and minimal bactericidal concentration
(MBC) assays
The MIC was determined by a broth microdilution
method with Mueller^Hinton broth (Becton Dickin-
son Italia, Milan, Italy), according to the procedures
outlined by the National Committee for Clinical
Laboratory Standards (Clinical and Laboratory
Standards institute/National Committee for Clinical
Table 1 Strains of bacteria tested in this study
Strains Host fish Year of isolation Location of isolation
Streptococcus dysgalactiae (0722XY) Acipenser schrenckii 2006 Hubei province, China
Edwardsiella ictaluri (HSN-1) Pelteobagrus fulvidraco 2006 Hubei province, China
Pseudomonas fluorescens (56-12-10) Ctenopharyngodon idella 1956 Hubei province, China
Aeromonas hydrophila (XS9141) Hypothalmichthys molitrix 1991 Hubei province, China
Vibrio harveyi (Ecgy0204) Lutjanus erythopterus 2002 Guangdong province, China
Escherichia coli (ATCC25922) A American Type Cultures Collection (ATCC) strain
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Laboratory Standards 2006), and an initial inoculum
of 5  105 CFUmL1was used. In brief,50 mL BHI or
TSBwas added to eachwell of 96-well plates,50 mL of
drug solution with appropriate concentration was
added to the ¢rst well, and then a serial twofold dilu-
tion was processed (it was not true for berberine hy-
drochloride, the detailed concentrations of the series
wells can be seen in the following tables), giving a
series of tested concentrations for berberine hydro-
chloride and enro£oxacin, as listed in Table 2. Fifty
microlitres of inocula with a concentration of
106 CFUmL1 logarithmic organisms was added to
each well, mixed thoroughly and incubated at 25 1C
for 24 h inamoist chamber before the visual determi-
nation of MICs. Wells without antimicrobial agents
andwells without bacteriawere set up and incubated
as controls. The ¢nal concentrations of bacteria
adopted were 5  105 CFUmL1. Minimal inhibi-
tory concentration was de¢ned as the lowest drug
concentration at which observable growth was
inhibited.
Minimal bactericidal concentrations of berberine
hydrochloride and enro£oxacin alone or in combina-
tion were determined by subculturing 10 mL of the
test dilutions without visible growth in MIC experi-
ments on to a fresh drug-free solid medium and incu-
bating further for18^24 h. The lowest concentration
of each drug that resulted in 499.9% reduction in
the initial inoculawas taken as MBC.
Combination antimicrobial susceptibility
testing
In interaction studies, E. ictaluri, E. coli and S. dysga-
lactiae were used to test the antibiotic combinations
by a checkerboard titration method using 96-well
polypropylene microtitre plates. The ranges of drug
dilutions used were shown as listed in Tables 4^6.
The media, inocula and conditions were the same as
those for MIC tests. The fractionary inhibitory con-
centration (FIC) index for combinations of two anti-
microbials was calculated by the formula
FIC index ¼ partial FIC berberine
þ partial FIC enrofloxacin
where partial FIC is the concentrationof drug in com-
bination/MIC of single drug.
The result of the sum allows to know if the
combination resulted in synergism, indi¡erence or
antagonism, according to following criteria:  1,
synergistic;1^2, indi¡erence;  2, antagonistic (Ca-
solari, Rossi, Baggio, Coppi, Zandomeneghi, Ruberto,
Farina, Fabio, Zanca & Castelli 2004).
Results
Antimicrobial activity
Minimal inhibitory concentrations of berberine hy-
drochloride against E. coli, E. ictaluri and S. dysgalac-
tiae were 300, 400 and 150 mgmL1, respectively,
and were shown in Table 1. These ¢ndings demon-
strate that berberine possesses good activity against
these organisms, especially against S. dysgalactiae.
Table 2 shows the MICs of enro£oxacin against six
strains of bacteria, A. hydrophila, P. £uorescens, S. dys-
galactiae, E. coli,V. harveyi and E. ictaluri; they were
0.4,1.6,0.8,0.025,0.8 and 0.025 mgmL1respectively.
These ¢ndings show that enro£oxacin was much
more e¡ective against E.coli and E. ictaluri than
against the others.
The results of antibacterial testing of berberine hy-
drochloride in combination with enro£oxacin
against E. coli, S. dysgalactiae and E. ictaluri are
shown inTables 3^5.
The MICs of berberine hydrochloride in combina-
tion with enro£oxacin against E. coli or E. ictaluri is
lower than that of berberine hydrochloride alone or
enro£oxacin alone against the two organisms.The re-
sults shown inTable 3 indicate that sub-MIC of berber-
ine hydrochloride increased the antibacterial e¡ect of
enro£oxacin against E. coli and E. ictaluri. Minimal in-
hibitory concentration of enro£oxacin against E. coli
decreased from 0.025 to 0.0125 mgmL1 when there
was 50 or100 mgmL1of berberine hydrochloride in
microtitre plate wells. When 150 or 200 mgmL1 of
berberine hydrochloride was used, the MIC of enro-
Table 2 Results of MIC test of berberine hydrochloride
against six strains of bacteria
Strains
Berberine hydrochloride concentrations
(lgmL 1)
500 400 300 200 150 100 70 40
XS9141 1 1 1 1 1 1 1 1
56-12-10 1 1 1 1 1 1 1 1
0722XY       1 1
HSN-1    1 1 1 1 1
Ecgy0204 1 1 1 1 1 1 1 1
ATCC25922   1 1 1 1 1 1
1, represents visible bacterial growth; , represents no visible
bacterial growth.
ATCC, American Type Cultures Collection; MIC, minimum inhi-
bitory concentration.
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£oxacin against E. coli decreased further to
0.00625 mgmL1. In the same way, sub-MIC of enro-
£oxacin also enhanced the antibacterial e¡ect of ber-
berine hydrochloride, lowered its MIC against E. coli
from 300 to 50 mgmL1 when 1/2MIC or 1/4MIC of
enro£oxacinwas used.The calculated FICwas 0.67, in-
dicating a synergism e¡ect.
A similar synergistic action against E. ictaluri be-
tween berberine hydrochloride and enro£oxacin
was observed (Table 6). Sub-MIC (450 mgmL1) of
berberine hydrochloride can reduce the MIC of enro-
£oxacin on E. ictaluri two to eight times, i.e., from
0.025 to 0.003125 mgmL1. In the same way, sub-
MIC of enro£oxacin can enhance the antibacterial
activity of berberine hydrochloride, and allows the
MIC against E. ictaluri to decrease from 300 mgmL1
go down to 50 mgmL1. The FIC calculated was
0.625.
Berberine hydrochloride did not increase the inhi-
bitory e¡ect of enro£oxacin against S. dysgalactiae
(Table 5). The FIC calculated was1.
The MBCs of berberine hydrochloride for E. coli,
S. dysgalactiae, E. ictaluri were 400, 300 and
500 mgmL1 respectively. The MBCs of enro£oxacin
for E. coli, S. dysgalactiae and E. ictaluri were 0.2, 3.2
and 0.1 mgmL1 respectively. The MBCs of berberine
hydrochloride in combination with enro£oxacin for
E. coli, S. dysgalactiae and E. ictaluri were 0.00625
mgmL1of enro£oxacin plus 300 mgmL1of berber-
ine hydrochloride, 0.4 mgmL1 of enro£oxacin plus
200 mgmL1of berberinehydrochloride and 0.00625
mgmL1 of enro£oxacin plus 300 mgmL1 of ber-
berine hydrochloride respectively. These results
demonstrated that the enro£oxacin enhanced the
bactericidal e¡ect of berberine hydrochloride and
vice versa.
Table 3 Results of MIC test of enro£oxacin against six
strains of bacteria
Stains
Enrofloxacin concentrations (lgmL 1)
1.6 0.8 0.4 0.2 0.1 0.05 0.1/4 0.1/8
XS9141    1 1 1 1 1
56-12-10  1 1 1 1 1 1 1
0722XY   1 1 1 1 1 1
HSN-1        1
Ecgy0204   1 1 1 1 1 1
ATCC25922        1
1, represents visible bacterial growth; , represents no visible
bacterial growth.
ATCC, American Type Cultures Collection; MIC, minimum inhi-
bitory concentration.
Table 4 Inhibitory test of berberine hydrochloride com-
bined with enro£oxacin to Escherichia coli (ATCC25922)
Agents and Concentration
Enrofloxacin (lgmL 1)
0.1/2 0.1/4 0.1/8 0.1/16 0.1/32 0
Berberine hydrochloride (mgmL 1)
400      
300      
200     1 1
150     1 1
100    1 1 1
50    1 1 1
0   1 1 1 1
1, represents visible bacterial growth; , represents no visible
bacterial growth.
ATCC, American Type Cultures Collection.
Table 5 Inhibitory test of berberine hydrochloride com-
bined with enro£oxacin to Streptococcus dysgalactiae
(0722XY)
Agents and concentration
Enrofloxacin (lgmL 1)
1.6 0.8 0.4 0.2 0.1 0.05 0
Berberine hydrochloride (mgmL 1)
300       
200       
150       
100   1 1 1 1 1
70   1 1 1 1 1
40   1 1 1 1 1
0   1 1 1 1 1
1, represents visible bacterial growth; , represents no visible
bacterial growth.
Table 6 Inhibitory test of berberine hydrochloride com-
bined with enro£oxacin to Edwardsiella ictaluri (HSN-1)
Agents and concentration
Enrofloxacin (lgmL 1)
0.1/2 0.1/4 0.1/8 0.1/16 0.1/32 0
Berberine hydrochloride (mgmL 1)
400      
300      1
200     1 1
150    1 1 1
100    1 1 1
50    1 1 1
0   1 1 1 1
1, represents visible bacterial growth; , represents no visible
bacterial growth.
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Discussion
TheMICs of berberine hydrochloride for theA. hydro-
phila, P. £uorescens,V. harveyi, E. coli, E. ictaluri and
S. dysgalactiae stains were  500,  500,  500,
400, 300 and 150 mgmL1, respectively, which are
much higher than those of commonly used antibio-
tics. S. dysgalactiae was most sensitive to berberine
hydrochloride among the organisms tested in the
present study. This ¢nding is in coincidence with a
previous study, which showed that the antibacterial
e¡ect of berberine on Staphylococcus aureus, Bacillus
subtilis were stronger than on E. coli (Wang, Yan &
Gao 2006). This results show that berberine
hydrochloride can inhibit the growth of E. ictaluri,
E. coli and S. dysgalactiae at a concentration
o400 mgmL1, but berberine hydrochloride
alone did not show e¡ective inhibition against
A. hydrophila, P. £uorescens andV. harveyi in vitro even
at a concentration of 500 mgmL1. Combination of
berberine hydrochloride and enro£oxacin showed a
signi¢cant synergistic action against E. ictaluri and
E. coli (FIC50.625 and 0.67 respectively), but did not
show sucha e¡ect on S. dysgalactiae (FIC51). Consid-
ering S. dysgalactiae is a Gram-positive bacterium,
and E. ictaluri and E. coli are Gram-negative bacteria,
does this mean that the synergistic action between
berberine hydrochloride and enro£oxacin can
only occur on Gram-negative bacteria? Of course, it
needs a more detailed study. This result clearly indi-
cated that berberine hydrochloride has signi¢cant
antibacterial activity against E. ictaluri and E. coli
when used together with enro£oxacin. The synergis-
tic action, however, has not been demonstrated
in vivo studies.
The ¢nding that the antibacterial e¡ect of berber-
ine hydrochloride on Gram-positive bacteria (S. aur-
eus, B. subtilis and S. dysgalactiae) was stronger than
on the Gram-negative bacteria tested (A. hydrophila,
P. £uorescens,V. harveyi, E. ictaluri and E. coli) prob-
ably owes to the di¡erence of structure and function
of bacterial cell wall partly.
Whether the combination of berberine hydro-
chloride and enro£oxacin can reduce the risk of
development of resistant bacteria to both antimicro-
bials also need further investigations.
Our results show that E. ictaluri and E. coli had
higher susceptibility to enro£oxacin than A. hydro-
phila, P. £uorescens, S. dysgalactiae andV. harveyi had.
The MIC value of enro£oxacin against E. coli
(ACTT25922) was in accordance with that reported
previously (Lykkeberg, Halling-Srensen & Jensen
2007). This result can be taken as a quality control
for MIC assay.
There were several researchers exploring the me-
chanism behind the antimicrobial activity of berber-
ine. There was a report that berberine sulphate was
bacteriostatic for streptococci and that sub-MICs of
berberine blocked the adherence of streptococci to
host cells (Sun, Courtney & Beachey1988). Berberine
speci¢cally blocks the synthesis and assembly of
Pap ¢mbriae on the surface of E. coli CI6 cell in the
presence of 200 mgmL1 berberine for 18 h (Sun,
Abraham & Beachey 1988). In the presence of
1^50 mgmL1berberine, adhesion and intracellular
invasionability of methicillin-resistant S. aureuswere
notably decreased (Yu, Kim, Cha, Kim, Lee, Choi &
You 2005). Berberine was also found to have e¡ects
on toxins and plasmids of bacteria. Berberine might
not allow the formation of active and intact cholera
toxins (Modak, Modak & Venkatraman1970). Berber-
ine also markedly inhibited the secretory response of
E. coli heat-stable enterotoxin in the infant mouse
model (Sack & Froehlich 1982). Berberine sulphate
has some e¡ects to eliminate the plasmids of E. coli
(Li,Wang & Hu 1994). In conclusion, berberine is a
multifunctional antimicrobial agent, which has a po-
tential to be used in aquaculture. Further studies are
de¢nitely needed to determine the exact underlying
mechanism of the antibacterial e¡ect of berberine
and the combination with antibiotics. Coptis chinen-
sis Franch, which is an important Chinese herb and
is an important source of berberine, has been used
widely in Chinese aquaculture to treat ¢sh diseases
and to promote ¢sh immune systemwith di¡erent le-
vels of success (Commission of Chinese Veterinary
Pharmacopoeia 2005).
Disease problem is amajor threaten to aquaculture
in China. Unfortunately, antimicrobial treatment is
currently the major control method. However, as in
manyof other countries, antibiotics are facing tough-
er control on the use on food-producing animals, in-
cluding on aquaculture ¢sh in China. Products from
plants are receiving greater attention for the substi-
tution of chemical antimicrobials for this purpose.
The ¢ndings of the present study proved that a Chi-
nese herb extract, berberine, was e¡ective in control-
ling some ¢sh pathogenic bacteria, suggesting its
potential as an antimicrobial agent for aquaculture
use, especially when used in combination with anti-
biotics. By this way, it will reduce the usage of anti-
biotics to a certain extent.
To our knowledge, this is the ¢rst study on the
inhibitory e¡ect of berberine hydrochloride against
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¢sh pathogenic bacteria when in combination with
antibiotics.
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